Prior studies in triple-negative breast cancer have implicated IGF2BP3 in the genesis and function of cancer stem cells, through direct regulation of SLUG transcripts, which in-turn regulates Sox2 [26]. This evidence concerns the gene IGF2BP3 and triple-negative breast carcinoma.